GENE ONLINE|News &
Opinion
Blog

2021-06-15| IPOSpecial

Is the Path to Public Market Smooth? A Candid Discussion on SPACs

by Daniel Ojeda
Share To
There are multiple ways for a company to raise money, from venture capital to the public offering of common stocks. One method that has garnered a lot of attention recently is the Special Purpose Acquisition Company (SPAC).
Recognizing the prominent role of SPACs in shaping the growth of biotech companies, an expert panel shared their experiences at the BIO Digital 2021 conference. The panel comprised of:

GO Prime with only $1.49 now

LATEST
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!